Open Access Editorial Article ID: IJPSDR-3-113

    JAK inhibitors: a promising direction for treating Rheumatoid Arthritis

    Pelechas Eleftherios*

    Rheumatoid Arthritis (RA) is a chronic auto inflammatory disease that causes incapacitating changes both the musculoskeletal system and the internal organs [1]. Tumor Necrosis Factor inhibitors (TNFi) promised a new revolutionary era in RA approximately 20 years ago. Since then, different TNFi molecules appeared in that direction. Nowadays, clinicians have also added in their armamentarium the first bio similar in order to combat RA. The main question is: do they have achieved their goal regarding their efficacy, and if yes, at what extent?


    Published on: Jun 9, 2017 Pages: 29-29

    Full Text PDF Full Text HTML DOI: 10.17352/ijpsdr.000013
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJPSDR